Reliability and Validity of the Glittre Activities of Daily Living Test in Multiple Sclerosis Patients
1 other identifier
observational
51
1 country
1
Brief Summary
Patients with Multiple Sclerosis (MS) have reduced functional capacity due to clinical symptoms of the disease, resulting in decreased participation in daily living activities and reduced quality of life. Evaluation of functional capacity and activities of daily living is very important in order to determine appropriate rehabilitation programs and increase the participation of patients in daily life activities. However, although there are many scales evaluating functional capacity and activities of daily living in people with disabilities, there is no specific assessment scale specific to MS patients. Therefore, this study was planned to investigate whether the Glittre Daily Living Activities (ADL) Test, which was developed to measure functional capacity in chronic obstructive pulmonary disease, is a valid and reliable measurement tool in MS patients. For this purpose, a total of 51 participants (25 MS patients and 26 healthy participants) evaluated with Glittre ADL Test. The relationship between Glittre ADL Test and 6-minute walk test, Notthingham Extended Daily Living Activities Index, Multiple Sclerosis Quality of Life Scale, Fatigue Severity Scale, Balance Assessment Systems Test (MiniBEST Test), Extended Disability Status Scale and 5-repetition sit-to-stand test evaluated with Pearson or Spearman correlation coefficient. For the known group validity, the difference between the patient and control groups compared with the test of the difference between the two means. For reliability, test retest performed. Reliability evaluated with the intraclass correlation coefficient. Hypothesis 1: Glittre ADL Test results in MS patients and healthy subjects are different. Hypothesis 2: Glittre ADL Test is reliable in MS patients. Hypothesis 3: Glittre ADL Test is valid for evaluating functional exercise capacity in MS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2019
CompletedFirst Submitted
Initial submission to the registry
November 26, 2019
CompletedFirst Posted
Study publicly available on registry
December 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 4, 2020
CompletedFebruary 12, 2021
February 1, 2021
1 year
November 26, 2019
February 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glittre Activities of Dailiy Living Test
Functional exercise capacity measurement
10 minute
Secondary Outcomes (7)
6 minute walk test (6MWT)
10 minute
Nottingham Extended Daily Living Activities Index (NGGYAI)
10 minute
Extended Disability Status Scale (EDSS)
minimum 30 minute
Fatigue Severity Scale
10 minute
Multiple Sclerosis Quality of Life İnstrument - 54 (MSQOL-54)
15 minute
- +2 more secondary outcomes
Study Arms (2)
Study Group
Multiple Sclerosis Patients
Control Group
Healthy Subjects
Interventions
The Glittre Activities of Daily Living (ADL) Test was used to evaluate functional exercise capacity.
Eligibility Criteria
Volunteers of the patients who applied to Hacettepe University Neurology Department, diagnosed with MS by specialist physician and referred to Hacettepe University Faculty of Health Sciences Physiotherapy and Rehabilitation Department for physiotherapy and rehabilitation program were included in the study.
You may qualify if:
- Between 18-65 years
- Relapsing Remitting Multiple Sclerosis (RRMS) type MS disease.
- Extended Disability Status Scale (EDSS) score of maximum 4.5
- No attacks during the last 3 months
- The medication has not been changed in the last 6 months.
- Getting more than 24 points from the Standardized Mini Mental Test.
You may not qualify if:
- Having had any musculoskeletal surgery.
- Using a walking aid or orthosis.
- Having a neurological disease other than MS.
- Having orthopedic or rheumatological problems that will affect function.
- Having a peripheral vestibular problem.
- Having a cardiovascular and pulmonary disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
Related Publications (16)
Langeskov-Christensen M, Heine M, Kwakkel G, Dalgas U. Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis. Sports Med. 2015 Jun;45(6):905-23. doi: 10.1007/s40279-015-0307-x.
PMID: 25739555BACKGROUNDSkumlien S, Hagelund T, Bjortuft O, Ryg MS. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med. 2006 Feb;100(2):316-23. doi: 10.1016/j.rmed.2005.04.022. Epub 2005 Jun 6.
PMID: 15941658BACKGROUNDSavci S, Inal-Ince D, Arikan H, Guclu-Gunduz A, Cetisli-Korkmaz N, Armutlu K, Karabudak R. Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil. 2005 Nov 30;27(22):1365-71. doi: 10.1080/09638280500164479.
PMID: 16372431BACKGROUNDNicholl CR, Lincoln NB, Playford ED. The reliability and validity of the Nottingham Extended Activities of Daily Living Scale in patients with multiple sclerosis. Mult Scler. 2002 Oct;8(5):372-6. doi: 10.1191/1352458502ms827oa.
PMID: 12356202BACKGROUNDSahin F, Yilmaz F, Ozmaden A, Kotevoglu N, Sahin T, Kuran B. Reliability and validity of the Turkish version of the Nottingham Extended Activities of Daily Living Scale. Aging Clin Exp Res. 2008 Oct;20(5):400-5. doi: 10.1007/BF03325144.
PMID: 19039280BACKGROUNDMoller AB, Bibby BM, Skjerbaek AG, Jensen E, Sorensen H, Stenager E, Dalgas U. Validity and variability of the 5-repetition sit-to-stand test in patients with multiple sclerosis. Disabil Rehabil. 2012;34(26):2251-8. doi: 10.3109/09638288.2012.683479. Epub 2012 May 22.
PMID: 22612360BACKGROUNDArmutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, Karabudak R. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007 Mar;30(1):81-5. doi: 10.1097/MRR.0b013e3280146ec4.
PMID: 17293726BACKGROUNDIdiman E, Uzunel F, Ozakbas S, Yozbatiran N, Oguz M, Callioglu B, Gokce N, Bahar Z. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample. J Neurol Sci. 2006 Jan 15;240(1-2):77-80. doi: 10.1016/j.jns.2005.09.009. Epub 2005 Nov 8.
PMID: 16277993BACKGROUNDKurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
PMID: 6685237BACKGROUNDCameron M, Mazumder R, Murchison C, King L. Mini Balance Evaluation Systems Test in people with multiple sclerosis: reflects imbalance but may not predict falls. Gait Posture. 2014;39(1):669. doi: 10.1016/j.gaitpost.2013.08.009. Epub 2013 Oct 17. No abstract available.
PMID: 24184138BACKGROUNDCompston A, Coles A. Multiple sclerosis. Lancet. 2008 Oct 25;372(9648):1502-17. doi: 10.1016/S0140-6736(08)61620-7.
PMID: 18970977BACKGROUNDMansson E, Lexell J. Performance of activities of daily living in multiple sclerosis. Disabil Rehabil. 2004 May 20;26(10):576-85. doi: 10.1080/09638280410001684587.
PMID: 15204511BACKGROUNDMarrie RA, Hanwell H. General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors. Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1046-57. doi: 10.1212/01.CON.0000433284.07844.6b.
PMID: 23917100BACKGROUNDStickland MK, Butcher SJ, Marciniuk DD, Bhutani M. Assessing exercise limitation using cardiopulmonary exercise testing. Pulm Med. 2012;2012:824091. doi: 10.1155/2012/824091. Epub 2012 Nov 19.
PMID: 23213518BACKGROUNDKarloh M, Araujo CL, Gulart AA, Reis CM, Steidle LJ, Mayer AF. The Glittre-ADL test reflects functional performance measured by physical activities of daily living in patients with chronic obstructive pulmonary disease. Braz J Phys Ther. 2016 Apr 8;20(3):223-30. doi: 10.1590/bjpt-rbf.2014.0155.
PMID: 27437713BACKGROUNDKaya G, Kose N, Salci Y, Armutlu K, Karakaya J, Tuncer A, Karabudak R. Reliability and validity of the glittre activities of daily living test in fully ambulatory multiple sclerosis patients. Ir J Med Sci. 2023 Oct;192(5):2379-2386. doi: 10.1007/s11845-022-03237-x. Epub 2022 Dec 1.
PMID: 36451004DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nezire KÖSE, Prof.
Hacettepe University
- STUDY CHAIR
Rana KARABUDAK, Prof.
Hacettepe University
- STUDY CHAIR
Meryem A TUNCER, Prof.
Haceetepe University
- PRINCIPAL INVESTIGATOR
Kadriye ARMUTLU, Prof.
Hacettepe University
- PRINCIPAL INVESTIGATOR
Yeliz SALCI, Asts. Prof.
Hacettepe University
- PRINCIPAL INVESTIGATOR
Jale KARAKAYA, Assoc. Prof.
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
November 26, 2019
First Posted
December 2, 2019
Study Start
October 1, 2018
Primary Completion
October 15, 2019
Study Completion
August 4, 2020
Last Updated
February 12, 2021
Record last verified: 2021-02